A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection.

NCT04225897 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
51
Enrollment
INDUSTRY
Sponsor class

Stopped Part A and Part B were completed but Pfizer terminated Part C due to strategic consideration. There were no safety concerns in the decision to stop Part C and no changes to the risk-benefit for participants who received RV521 in the study.

Conditions

Interventions

Sponsor

Pfizer